A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

NCT01100164 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

INSOMNIA

Interventions

DRUG: Eszopiclone
DRUG: Zopiclone

Sponsor

Eurofarma Laboratorios S.A.